Sequencing continues to have the potential to rework scientific microbiology and even public well being by enabling the simultaneous, hypothesis-free identification of a number of disease-causing organisms (together with micro organism, viruses, fungi and parasites). A number of approaches for any such testing exist – from sampling of microbes in sources of an infection to newer cell-free approaches from physique fluids. Regardless of its large promise, sequencing has not seen the routine uptake many predicted attributable to quite a lot of technical, scientific and broader structural causes.
Whereas implementation in routine observe stays in early phases, the potential impression on healthcare supply and affected person outcomes warrants severe consideration from forward-looking healthcare leaders.
Be a part of us for a dynamic moderated dialogue between two widely known consultants within the subject of microbiology, Charles Chiu, MD PhD, and Brad Perkins, MD, as they talk about the way forward for sequencing in scientific microbiology.
Dialogue Highlights:
- Sequencing’s transformative potential in diagnostics.
- Actual-world affected person impression and success tales.
- Assessing the place we’re within the adoption cycle.
- Advances in numerous kinds of methodologies, infrastructure, and approaches.
- Addressing unmet wants in infectious illness diagnostics and healthcare supply.
- Constructing the scientific proof base to drive broader adoption.
- Overcoming boundaries via innovation, collaboration, and guideline growth.
- Envisioning the long run.
